Phitonex develops next-generation fluorescent labels and precision molecular-scale optics for high-resolution biomarker detection on single cells. Its platform allows precise engineering of optical properties to enable high-resolution analysis by high-throughput flow cytometry. The company is led by Co-Founder and CSO Chris Dwyer, Ph.D., and Chairman and co-founder Alvin Lebeck, Ph.D. It closed a $2M seed funding round led by private investors. Phitonex intends to use the funds to scale, take its labels to market, and expand and accelerate development of its precision optics for various high-resolution biology applications. The company will release NovaFluor test kits for multicolor staining this fall and plans to release additional labels soon.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2019